Biomedical Institutions, Biomedical Funding, and Public Policy

by H. Hugh Fudenberg (Editor)

Overview

The world is on the threshold of a great new industrial revolution, a 1 scientific-industrial revolution. Recombinant DNA technology and hybridoma technology ("monoclonal antibodies") have already provided unique investment opportunities for venture capitalists. Hence published reports of biomedical research are no longer restricted to scientific journals, but now appear regularly not only in weekly news­ 2 magazines like Time and U. S. News & World Report,3 but also in the financial sections of The New York Times,4 The Wall Street Journal,S 6 8 Business Week, Fortune,7 and The Economist, as well as in such sk 9 market advisory publications as New Issues and Inc. (The Magazine for Growing Companies). 10 These publications now appear to be as important to biomedical scientists in keeping abreast of new scientific developments in biotechnology as is Current Contents. (The costs of health­ cost provision and of fundamental biomedical research are now also being followed by such media. ) Conversely, Wall Street financial bro­ kers increasingly no longer confine their reading to economic journals but are also perusing Nature,ll Science,12 and Science N 13 for infor­ ews mation on both fiscal and scientific advances in these areas. It is obvious that the information explosion in biotechnology is crossing traditional boundaries (e. g. , ref. 14). This volume is the second of several that are intended to inform both the biomedical community and interested intelligent laymen of the political and economic implications of biomedical research.

Product Details

ISBN-13:	9781468444506
Publisher:	Springer US
Publication date:	02/24/2013
Edition description:	Softcover reprint of the original 1st ed. 1983
Pages:	212
Product dimensions:	6.10(w) x 9.25(h) x 0.02(d)

Table of Contents

1 Excellence and Creativity in Science.- 2 Basic Biomedical Research: A Cost-Benefit Analysis.- 3 Molecular Biology: Application to Prenatal Diagnosis of Genetic Disorders of Hemoglobin.- 4 Economic Impact of Recombinant DNA Technology.- 5 Foundations and Their Contributions to the Shaping of Health Policy.- 6 Differing Approaches to Biomedical Research: The NIH, the Academic Medical Center, and the Pharmaceutical Industry.- 7 World Endemic Disease: Costs and Potential Fiscal Benefits of Medical Research.- 8 The World Health Organization: Its Influence on Worldwide Research Policies.- 9 Hisompatibility Workshops: Economic Impact.- 10 A Model for the Funding of Clinical Faculty in a Municipal Hospital.- 11 Economics of American Health Care.